Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2005-06-14
2005-06-14
Saidha, Tekchand (Department: 1652)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C435S021000, C435S196000, C536S023200, C530S350000
Reexamination Certificate
active
06905689
ABSTRACT:
A conjugate of a tissue non-specific alkaline phosphatase (tns-AP) and dextran which can be obtained by reacting unglycosylated tns-AP with activated dextran by incubation in aqueous solution, stopping the reaction and isolating the conjugate from the solution. The conjugate obtained in this manner is suitable as a standard for the determination of alkaline phosphatase.
REFERENCES:
patent: 4931392 (1990-06-01), Rehner et al.
patent: 4950609 (1990-08-01), Tischer et al.
patent: 5434067 (1995-07-01), Michaelis et al.
patent: 5514559 (1996-05-01), Markert-Hahn et al.
patent: 5834273 (1998-11-01), Rutasugi et al.
patent: 0 418 523 (1991-03-01), None
patent: 0 471 125 (1992-02-01), None
patent: WO 93/01498 (1993-01-01), None
Anderson, et al., (1991), Int. J. Cancer, “Binding of epidermal growth factor-dextran conjugates to cultured glioma cells”, vol.: 47, pp. 439-444.
Balbas, P., (2001), Molecular Biotechnology, “Understanding the art of producing protein and nonprotein molecules inescherichia coli”, vol.: 19, pp. 251-267.
Bretaudiere and Spillman, (1984), Verlag Chemie, “Methods of enzymatic analysis”, vol.: IV, Third Edition, pp. 75-83.
Bradford, M.M., (1976), Analytical Biochemistry, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding”, vol.: 72, pp. 248-254.
Fukushi, M., et al., (1998), Biochemical and Biophysical Research Communications, “Intracellular retention and degradation of tissue-nonspecific alkaline phosphatase with a Gly317→Asp substitution associated with lethal hypophosphatasia”, vol.: 246, pp. 613-618.
Harris, H., (1989), Clinica Chimica Acta, “The juman alkaline phosphatases: What we know and shat we don't know”, vol.: 186, pp. 133-150.
Holmberg, A., et al., (1993), Bioconjugate Chem., “Preparation of sulfhydrylborane-dextran conjugates for boron neutron capture therapy”, vol.: 4, pp. 570-573.
Hooper, N.M, (1997), Clinica Chimica Acta, “Glycosyl-phosphatidylinositol anchored membrane enzymes”, vol.: 266, pp. 3-12.
Lilie, H., et al., (1998), Curr. Opin. Biotechnol., “Advances in refolding of proteins produced inE. coli”, vol.: 9, pp. 497-501.
Lovqvist, A., et al., (1993), Cancer Biotherapy, “Binding, internalization and excretion of TGFα-dextran associated radioactivity in cultured human glioma cells”, vol.: 8(4), pp. 345-356.
Makrides, S.C., (1996), Microbiological Reviews, “Strategies for achieving highj-level expression of genes inEscherichia coli”, vol.: 60(3), pp. 512-538.
Maldonado, O., et al., (1998), J. Clin Gastroenterol, “Extremely high levels of alkaline phosphatase in hospitalized patients”, vol.: 27(4), pp. 342-345.
Miura, M., et al., (1994), Ann Clin Biochem, “Differences between the sugar moieties of liver- and bone-type alkaline phosphatases: a re-evaluation”, vol.: 31, pp. 25-30.
Moss, D.W., (1992), Clin. Chem., “Perspectives in alkaline phosphatase research”, vol.: 38(12), pp. 2486-2492.
Mulivor, R.A., et al., (1985), J. Lab. Clin. Med., “Quantitative analysis of alkaline phoshatases in serum and amniotic fluid: Comparison of biochemical and immunologic assays”, vol.: 105(3), pp. 342.348.
Nosjean, O., et al., (1997), Biochem. J., “Human tissue non-specific alkaline phosphatases: sugar-moiety-induced enzymic and antigenic modulations and genetic aspects”, vol.: 321, pp. 297-303.
Oda, K., et al., (1999), J. Biochem., “A general method for rapid purification of soluble versions of glycosylphosphatidylinositol-anchored proteins expressed in insect cells: An application for human tissue-nonspecific alkaline phosphatase”, vol.: 126, pp. 694-699.
Olsson, P., et al., (1994), Int. J. Cancer., “Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured human squamous-carcinoma cells”, vol. 56, pp. 529-537.
Reddy, S., et al., (1995), Biochemistry, “NΣ-(Carboxymethyl) lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins”, vol.: 34, pp. 10872-10878.
Romagnoli, E., et al., (1998), Clin. Chem. Lab. Med., “Assessment of serum total and bone alkaline phosphatase measurement in clinical practice”, vol.: 36(3), pp. 163-168.
Silve, C., (1994), Current Opinion in Rheumatology., “Hereditary hypophosphatasia and hyperphosphatasia”, vol.: 6, pp. 336-339.
Singh, R., et al., (2001), Diabetologia, “Advanced glycation end-products: a review”, vol.: 44, pp. 129-146.
Sjostrom, A., et al., (1997), Int. J. Cancer., “Binding, internalization and degradation of EGF-Dextran conjugates in two human bladder-cancer cell lines”, vol.: 70, pp. 383-389.
Thomalley, P.J., et al., (1999), Biochem. J., “Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose”, vol.: 344, pp. 109-116.
Tietz, N.W., et al., (1983), J. Clin. Chem. Clin. Biochem., “IFCC methods for the measurement of catalytic concentration of enzymes”, vol.: 21(11), pp. 731-748.
Weiss, M.J., et al., (1988), The Journal of Biological Chemistry, “Strujcture of the human liver/bone/kidney alkaline phosphatase gene”, vol.: 263(24), pp. 12002-12010.
Weiss, M.M., et al., (1986), Proc. Natl. Acad. Sci. USA, “Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase”, vol.: 83, pp. 7182-7186.
Wiwanitkit, V., (2001), BMC Family Practice 2001, “High serum alkaline phosphatase levels, a study in 181 Thai adult hospitalized patients”, vol.: 2(2), 4 page article.
Meier Thomas
Schmuck Rainer
Schneidinger Bernd
Shao Zhixin
McDonnell Boehnen & Hulbert & Berghoff LLP
Roche Diagnostics Operations Inc.
Saidha Tekchand
LandOfFree
Conjugate of a tissue non-specific alkaline phosphatase and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugate of a tissue non-specific alkaline phosphatase and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugate of a tissue non-specific alkaline phosphatase and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3516303